Skip to content
Screener

Oruka Therapeutics, Inc. ORKA Increase Decrease In Accounts Payable Related Parties

Increase Decrease In Accounts Payable Related Parties at other companies

Madison Square Garden Sports logo
Madison Square Garden SportsMSGS
$686K-75.6%
Oruka Therapeutics, Inc. logo
Oruka Therapeutics, Inc.ORKA
$3M+158%
Oruka Therapeutics, Inc. logo
Oruka Therapeutics, Inc.ORKA
$3M+158%
Laser Photonics Corporation logo
Laser Photonics CorporationLASE
$80.37K
AMC Robotics Corporation logo
AMC Robotics CorporationAMCI
$1.8K+100%
Great Elm Group, Inc. logo
Great Elm Group, Inc.GEG
-$4K

Other financials

Income statement

See full
Revenue-
Operating income-$36.4M-45.2%
Net income-$31.8M-51.5%
EPS (diluted)-$0.46+93.4%

Balance sheet

See full
Cash & equivalents$49.5M-40.7%
Total debt$1.8M+90.8%
Total equity$486.7M+33.4%
Total assets$504.5M+33.8%

Cash flow

See full
Operating cash flow-$23.6M-13.0%
CapEx$73.0K+462%
Free cash flow-$23.7M-13.3%

Valuation

See full
Market cap$5.96B+1,120%
Enterprise value$5.91B+1,289%

Returns & leverage

See full
Return on equity-27.3%-11.1pp
Debt / equity0.0×
Current ratio23.8×-6.3×

Where this comes from

Reported directly by Oruka Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayableRelatedParties.

The source filing: Oruka Therapeutics, Inc.’s 10-Q, filed May 13, 2026.

Filed
May 13, 2026, 4:01 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001213900-26-055769
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Accounts payable(493)83
Accrued expenses and other current liabilities(1,304)2,317
Operating lease liability(125)(21)
Related party accounts payable and other current liabilities2,995(5,205)
Net cash used in operating activities(23,578)(20,869)
Cash flows from investing activities:
Purchases of property and equipment(73)(13)
Purchases of marketable securities(90,834)(44,290)

Item 1. Financial Statements (Unaudited)

FAQ

What is Oruka Therapeutics, Inc.'s increase decrease in accounts payable related parties?
Oruka Therapeutics, Inc. (ORKA) reported increase decrease in accounts payable related parties of $3M in Q1 2026.
How has Oruka Therapeutics, Inc.'s increase decrease in accounts payable related parties changed year-over-year?
Oruka Therapeutics, Inc.'s increase decrease in accounts payable related parties increased by 157.5% year-over-year, from -$5.21M to $3M.
What does increase decrease in accounts payable related parties mean?
Tracks the net change in outstanding balances owed to affiliated entities or related parties. Monitoring this helps identify potential conflicts of interest or changes in the financing structure between the company and its partners.

Ask your AI about Oruka Therapeutics, Inc.'s increase decrease in accounts payable related parties.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude